EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MoGraphDRP: Multi-omics and graph fusion with bilinear attention for predicting drug sensitivity

Zahra Ahmadi, Jamshid Pirgazi iD, Ali Ghanbari Sorkhi iD

PLOS One · 06.03.2026 · 21 (3) · e0341458

DOI: 10.1371/journal.pone.0341458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.03.2026. Verfasst von Zahra Ahmadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Electrical and computer Engineering, Department of Computer Engineering, University of Science and Technology of Mazandaran, Behshahr, Ira…. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate prediction of drug response in cancer cells is a fundamental step toward achieving precision medicine and designing personalized therapies. In this study, a multi-branch deep learning framework is proposed that integrates multi-omics cellular data including gene expression, mutation, methylation, and biological pathways with structural features of drugs (molecular graphs and various chemical fingerprints) to enable drug response prediction. The graph structure of the drug is modeled using a three-layer Graph Convolutional Network (GCN), and chemical fingerprints are compressed using MLP networks. These multiple representations of drugs are integrated and then combined with cellular features in a Multi-head Bilinear Attention module to model the complex interactions between cells and drugs. In the final stage, an ensemble model based on XGBoost is used to refine the outputs. The MoGraphDRP model demonstrates significantly higher accuracy in drug response prediction compared to existing state-of-the-art methods. Experimental results show that the MoGraphDRP model outperforms advanced methods such as BANDRP, DeepCDR, and DeepTTA, achieving PCC = 0.9689, RMSE = 0.6622, and R² = 0.9388. This model not only accurately reconstructs missing IC50 values but also effectively distinguishes between sensitive and resistant drugs in unknown combinations. The MoGraphDRP framework can serve as a powerful, interpretable, and reliable tool for analyzing drug response and designing preclinical treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsGraph Neural NetworksHumansMultiomicsDeep LearningBoosting Machine Learning Algorithms

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Electrical and computer Engineering, Department of Computer Engineering, University of Science and Technology of Mazandaran, Behshahr, Iran.

ORCID-Profile: Jamshid Pirgazi, Ali Ghanbari Sorkhi

Zitieren

APA

Ahmadi, Z., Pirgazi, J., & Sorkhi, A. G. (2026). MoGraphDRP: Multi-omics and graph fusion with bilinear attention for predicting drug sensitivity. PLOS One, 21(3), e0341458. https://doi.org/10.1371/journal.pone.0341458

Vancouver

Ahmadi Z, Pirgazi J, Sorkhi AG. MoGraphDRP: Multi-omics and graph fusion with bilinear attention for predicting drug sensitivity. PLOS One. 2026;21(3):e0341458. doi:10.1371/journal.pone.0341458

BibTeX
@article{Ahmadi2026,
  author = {Ahmadi, Zahra and Pirgazi, Jamshid and Sorkhi, Ali Ghanbari},
  title = {MoGraphDRP: Multi-omics and graph fusion with bilinear attention for predicting drug sensitivity},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0341458},
  doi = {10.1371/journal.pone.0341458}
}
Kostenlos starten →